Virgin Galactic Holdings, Inc

Virgin Galactic Holdings, Inc. is a U.S.-based aerospace and space travel company that designs, manufactures, and operates a spaceflight system for human spaceflight. Its business includes suborbital space missions for private astronauts, researchers, and government customers, along with related ground operations, testing, and post-flight maintenance.

−17 413,1 %

−4 613,0 %

−18 063,9 %

−78,1 %

1.78

1.78

— Virgin Galactic Holdings, Inc
%
Spaceflight services55% Crewed suborbital flights sold to private astronauts and other customers.
Astronaut community access fees25% Access and reservation-related fees tied to future spaceflight demand.
Research and payload missions15% Flights carrying scientific payloads and researchers for experiments.
Spaceflight system development5% Design, engineering, and testing work for next-generation vehicles.

Virgin Galactic sells access to space to private individuals who want a suborbital flight experience, and it also...

  • Private astronautsprimary

    Individuals purchasing suborbital flights for personal space travel and the astronaut experience

  • Researchers and scientific institutionssecondary

    Customers buying research flights and payload access for experiments

  • Government agenciessecondary

    Public-sector customers using spaceflight services for missions or research

  • Astronaut community / reservation holdersprimary

    Prospective customers paying access fees or holding future flight reservations

Virgin Galactic is headquartered in the United States and its operations are centered on U.S...

  • Headquartered in the United States
  • Spaceport America in New Mexico is a core operating site
  • Most suppliers and operations are located in the U.S.
  • Flight testing and commercial operations are U.S.-based
  • Geography matters mainly through launch-site and supply-chain access

Virgin Galactic’s strategy is to complete development of its next-generation Delta Class spaceships and transition into...

01
Develop and certify Delta Class vehiclesmedium-term

Next-generation spacecraft are the basis for future commercial service and capacity expansion

02
Restart commercial spaceflight operationsshort-term

Revenue depends on resuming flight activity and converting reservations into missions

03
Grow backlog and reservation baseshort-term

Reservations provide visibility into future demand and help support commercialization

04
Scale manufacturing and support infrastructuremedium-term

Higher flight volume requires more vehicles, personnel, and facilities

Virgin Galactic faces execution risk in developing and certifying new spacecraft, because delays or technical issues...

critical

Human spaceflight safety risk

Accidents or anomalies could halt operations and damage customer trust

Scope
Passengers, crew, and flight systems
Materiality
high
high

Delta Class development and flight-test execution risk

Commercial service depends on successful vehicle build, testing, and certification

Scope
Next-generation spaceships and launch vehicles
Materiality
high
high

Liquidity and financing risk

Fleet expansion and commercialization require substantial capital before scale benefits arrive

Scope
Manufacturing, testing, and operating cash needs
Materiality
high
medium

Supply-chain and trade-policy risk

Tariffs, export controls, or supplier disruptions can raise costs or delay components

Scope
U.S.-centric suppliers and third-party subassembly providers
Materiality
medium
medium

Litigation and contingent liability risk

Class-action and other claims can require settlement payments and legal expense

Scope
Shareholder and operational litigation
Materiality
medium
Revenue recognition for access fees and spaceflights
Can create quarter-to-quarter volatility in reported revenue
Contingent liabilities and legal settlements
Affects accrued liabilities and cash outflows
Capitalized property, equipment, and development costs
Affects operating expense timing and asset values
Stock-based compensation and equity issuance
Impacts EPS and shareholder dilution

: 29/04/2026